Elekta (EKTA) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
8 Jul, 2026Executive summary
Net sales grew 2% year-over-year in constant currencies to SEK 4,695M, driven by strong performance in Europe and APAC, while the US and China declined.
Order growth accelerated in Q3, with all regions and business lines contributing; book-to-bill ratio reached 1.15, up from 0.98 year-over-year.
Adjusted gross margin improved to 37.1% due to price increases and favorable product mix, especially from services.
Adjusted EBIT margin rose to 11.7%, supported by gross margin gains and higher amortization from recent product launches.
Record high Q3 cash flow after investments at SEK 730M, supported by higher EBITDA, lower investments, and reduced working capital.
Financial highlights
Service business grew 10% year-over-year, while solution sales declined 4% due to lower US and China volumes.
Net income reached SEK 336M; EPS was SEK 0.89, up from SEK 0.80 last year.
Adjusted EPS reached SEK 0.94, up from SEK 0.88 year-over-year.
Rolling 12-month cash flow from operating activities was SEK 2.38B; cash conversion at 79%.
Cost reduction initiatives delivered SEK 264M in annual run-rate savings for the first nine months, ahead of plan.
Outlook and guidance
Full-year 2024-25 net sales expected to be broadly stable; EBIT margin to be lower than 2023-24.
Targeting EBIT margin of 14% or higher beyond 2024-25, driven by product portfolio strength and demand.
Near-term outlook cautious for US and China due to lower installation volumes and regulatory timing.
Latest events from Elekta
- Margin expansion, software growth, and asset-light upgrades drive sustainable, profitable growth.EKTA
Investor update9 Jul 2026 - AI-driven adaptive radiotherapy and unified software drive adoption, margin, and upgrade growth.EKTA
Investor update8 Jul 2026 - Profitable growth and margin expansion achieved despite Q4 sales decline and inflation.EKTA
Q4 23/248 Jul 2026 - Sales and margins declined, but new products and cost savings support H2 growth outlook.EKTA
Q2 24/258 Jul 2026 - Q4 margin hit a five-year high, but R&D impairment led to a net loss; outlook remains strong.EKTA
Q4 24/258 Jul 2026 - Turnaround plan targets mid-single digit sales growth and 14–16% EBIT margin by FY28/29.EKTA
CMD 202618 Jun 2026 - Profitability and cash flow surged on cost savings, despite SEK sales decline and impairments.EKTA
Q4 25/261 Jun 2026 - Adjusted gross margin rose to 38.3% as restructuring to yield SEK 500M+ savings from Q1.EKTA
Q3 25/2629 Apr 2026 - Four strategic priorities and a new model target SEK 500M+ savings and global growth.EKTA
Strategy update9 Apr 2026